JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5276
Humacyte
HUMA
$133M
| $149K | ﹤0.01% |
47,831
-14,141
| -23% | -$47.6K |
2021 Q4
9 quarters
|
|
5277
Columbia Diversified Fixed Income Allocation ETF
DIAL
$376M
| $149K | ﹤0.01% |
8,366
+8,357
| +92,856% | +$148K |
2023 Q3
2 quarters
|
|
5278
Telefônica Brasil
VIV
$20.2B
| $148K | ﹤0.01% |
14,712
-44,432
| -75% | -$467K |
2022 Q2
7 quarters
|
|
5279
Stoke Therapeutics
STOK
$1.57B
| $148K | ﹤0.01% |
10,944
-7,189
| -40% | -$43.6K |
2019 Q3
18 quarters
|
|
|
TEAF
5280
DELISTED
Ecofin Sustainable & Social Impact Term Fund
TEAF
| $148K | ﹤0.01% |
12,500
| – | – |
2023 Q4
1 quarter
|
|
5281
NewtekOne
NEWT
$323M
| $148K | ﹤0.01% |
13,415
-5,870
| -30% | -$69.2K |
2015 Q4
33 quarters
|
|
|
NNDM
5282
Nano Dimension
NNDM
$331M
| $147K | ﹤0.01% |
52,933
+192
| +0.4% | +$495 |
2021 Q1
12 quarters
|
|
|
AEVA
5283
Aeva Technologies
AEVA
$1.02B
| $147K | ﹤0.01% |
37,493
-9,163
| -20% | -$44.3K |
2021 Q2
11 quarters
|
|
|
OSG
5284
DELISTED
Overseas Shipholding Group Inc.
OSG
| $147K | ﹤0.01% |
23,012
-18,004
| -44% | -$107K |
2017 Q3
26 quarters
|
|
5285
CALL
FS KKR Capital
FSK
$2.99B
| $147K | ﹤0.01% |
+7,700
| New | +$152K |
2024 Q1
0 quarters
|
|
5286
Offerpad Solutions Inc. Class A Common Stock
OPAD
$14.8M
| $147K | ﹤0.01% |
1,812
+1,800
| +15,000% | +$158K |
2021 Q3
10 quarters
|
|
|
RVPH
5287
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $146K | ﹤0.01% |
1,933
+1,887
| +4,102% | +$150K |
2023 Q4
1 quarter
|
|
5288
Innovator US Equity Buffer ETF June
BJUN
$246M
| $146K | ﹤0.01% |
+3,873
| New | +$142K |
2024 Q1
0 quarters
|
|
5289
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$359M
| $145K | ﹤0.01% |
1,561
-99,804
| -98% | -$8.35M |
2016 Q2
31 quarters
|
|
5290
Metagenomi Therapeutics
MGX
$38.5M
| $145K | ﹤0.01% |
+13,747
| New | +$158K |
2024 Q1
0 quarters
|
|
5291
SkinHealth Systems
SKIN
$76.1M
| $145K | ﹤0.01% |
32,554
-22,042
| -40% | -$71.6K |
2020 Q4
13 quarters
|
|
5292
NextNav
NN
$2.24B
| $144K | ﹤0.01% |
21,945
-17,621
| -45% | -$78.5K |
2022 Q2
7 quarters
|
|
5293
NLI Holdings
NL
$341M
| $144K | ﹤0.01% |
19,653
+8,283
| +73% | +$46.6K |
2016 Q4
29 quarters
|
|
5294
ProShares Ultra NASDAQ Biotechnology
BIB
$89.8M
| $144K | ﹤0.01% |
2,500
| – | – |
2022 Q4
5 quarters
|
|
5295
Nokia
NOK
$61.4B
| $142K | ﹤0.01% |
40,230
+1,505
| +4% | +$5.35K |
2013 Q2
43 quarters
|
|
5296
CALL
Acadia Pharmaceuticals
ACAD
$3.4B
| $142K | ﹤0.01% |
+7,700
| New | +$191K |
2024 Q1
0 quarters
|
|
|
CALB
5297
DELISTED
California BanCorp Common Stock
CALB
| $142K | ﹤0.01% |
6,469
+1,042
| +19% | +$24.5K |
2023 Q3
2 quarters
|
|
|
KWY
5298
Kingsway Corp
KWY
$275M
| $142K | ﹤0.01% |
17,056
+6,184
| +57% | +$53.1K |
2023 Q1
4 quarters
|
|
|
LKFT
5299
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.92B
| $142K | ﹤0.01% |
4,401
+4,395
| +73,250% | +$163K |
2019 Q1
20 quarters
|
|
5300
Saga Communications
SGA
$52.9M
| $142K | ﹤0.01% |
6,346
+126
| +2% | +$2.92K |
2017 Q4
25 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.